The role of genetics in pancreatic cancer: Are you at risk?

Pancreatic cancer, a highly aggressive disease, often diagnosed late, has a low survival rate. Genetic testing provides insights into individual risk and personalized treatment approaches. Mutations in genes like KRAS, BRCA1, and BRCA2 are significant, and targeted therapies are being developed. Germline mutations can identify individuals at risk, leading to enhanced surveillance and preventive measures.